Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Lymphocytic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (John F Seymour) · john.seymour@petermac.org · +61385595000
Alfred Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (Constantine Tam) · Constantine.tam@alfred.org.au · +61390765531
Monash Medical Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Stephen Opat) · Stephen.Opat@monash.edu · +6139594 6666

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic Lymphocytic Leukemia · Leukemia, Lymphocytic · Leukemia, B-cell

IsraelRecruitingPHASE3

Anaheim, United States · Cerritos, United States

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Irvine, United States

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Beijing, China